Mobia Medical (previously MicroTransponder) plans IPO

MicroTransponder (now renamed Mobia Medical) developed the Vivistim&#x2122; system intended for the treatment of stroke. The implant is based on the idea that synchronizing vagus nerve stimulation with movement increases neural plasticity in the brain, resulting in enhanced recovery. In May 2017 MicroTransponder presented results from its Vivistim&#x2122; Stroke Rehabilitation trial. The objective…